Mucommune
Pre-clinicalDevelops microbiome-based therapeutics for inflammatory and autoimmune diseases.
Founded
2018
Focus
AntibodiesBiologics
About
Develops microbiome-based therapeutics for inflammatory and autoimmune diseases.
Funding History
2Total raised: $18.5M
Series A$15MUndisclosedFeb 15, 2023
Seed$3.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile